Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Hyperosmotic stimuli activate polycystin proteins to aid in urine concentration
Karla M. Márquez-Nogueras, Ryne M. Knutila, Virdjinija Vuchkovska, Charlie Yang, Patricia Outeda, Darren P. Wallace, Ivana Y. Kuo
Karla M. Márquez-Nogueras, Ryne M. Knutila, Virdjinija Vuchkovska, Charlie Yang, Patricia Outeda, Darren P. Wallace, Ivana Y. Kuo
View: Text | PDF
Research Article Cell biology Nephrology

Hyperosmotic stimuli activate polycystin proteins to aid in urine concentration

  • Text
  • PDF
Abstract

Autosomal dominant polycystic kidney disease (ADPKD) is caused by mutations in PKD1 or PKD2, which encode polycystin-1 (PC1) and polycystin-2 (PC2), respectively. These proteins are thought to form a signaling complex that can flux cations, including calcium. One of the earliest symptoms in ADPKD is a decline in the concentrating ability of the kidneys, occurring prior to cyst formation. We reasoned that hyperosmolality stimulates the polycystin complex, and that the loss of this function impairs water reabsorption. We found that hyperosmolality resulted in the phosphorylation of microtubule-associated protein 4 (MAP4) in a PC1-dependent manner, which then elicited ER-localized PC2 calcium signals. ER-localized PC2 hyperosmotic calcium signals were required for trafficking of the water channel aquaporin (AQP2). Precystic PC1-KO and PC2-KO murine kidneys had cytosol-localized AQP2 and diluted urine compared with their respective controls. Kidney tissue sections from ADPKD patients showed decreased AQP2 apical membrane localization in cystic and noncystic tubules. Our study demonstrates that osmolality is a physiological stimulus of the polycystin complex, and loss of polycystin osmosensing results in impaired water reabsorption via AQP2. This likely contributes to the declined concentrating ability of the kidneys and high circulating vasopressin levels in patients with ADPKD.

Authors

Karla M. Márquez-Nogueras, Ryne M. Knutila, Virdjinija Vuchkovska, Charlie Yang, Patricia Outeda, Darren P. Wallace, Ivana Y. Kuo

×

Figure 6

Hyperosmotic aquaporin 2 (AQP2) trafficking to the membrane is impaired in PC1-KO and PC2-KO IMCD3 cells and localizes to the cytoplasm of CDs from PC1-KO and PC2-KO mice.

Options: View larger image (or click on image) Download as PowerPoint
Hyperosmotic aquaporin 2 (AQP2) trafficking to the membrane is impaired ...
(A–C) Representative immunofluorescent staining of IMCD3 CTL cells (A), PC1-KO cells (B), and PC2-KO cells (C) labeling AQP2 (red) and MAP4 (green) at 300 mOsm (top) and after hyperosmotic stimuli (400 mOsm, bottom). Scale bars: 10 μm. Hyperosmotic stimuli induced trafficking of AQP2 in the membrane of IMCD3 CTL cells but not in PC1-KO or PC2-KO cells. (D) Reexpression of full-length PC2 (cyan, top panel) restored AQP2 (red) trafficking to the membrane after hyperosmotic stimuli but not the PC2-D511V variant (cyan, lower panel) in IMCD3 PC2-KO cells. Scale bars: 10 μm. White arrows highlight AQP2 staining in membrane. (E) AQP2 is localized to the membrane with 100 nM AVP in CTL and PC2-KO IMCD3 cells. Scale bars: 10 μm. (F and G) AQP2 (red) and MAP4 (green) in kidney slices from CTL mice (top panel) and PC1-KO mice (F) or PC2-KO mice (G) (bottom panels). Scale bars: 10 μm. (H and I) Line scan of localized apical staining of AQP2 (red) and MAP4 (green) in kidney slices from CTL mice (H) versus cytosolic in PC2-KO (I) mice.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts